UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of medicinal chemistry, ISSN 0022-2623, 09/2015, Volume 58, Issue 18, pp. 7370 - 7380
Glucagon-Like Peptide 1 - administration & dosage | Glucagon-Like Peptides - administration & dosage | Humans | Half-Life | Crystallography, X-Ray | Male | Structure-Activity Relationship | Glucagon-Like Peptide-1 Receptor - metabolism | Glucagon-Like Peptides - pharmacology | Liraglutide - pharmacology | Swine | Injections, Subcutaneous | Glucagon-Like Peptides - chemistry | Swine, Miniature | Cell Line | Cricetinae | Glucagon-Like Peptide 1 - analogs & derivatives | Glucagon-Like Peptide 1 - pharmacology | Models, Molecular | Glucagon-Like Peptide 1 - chemistry | Rats, Sprague-Dawley | Administration, Intravenous | Animals | Mice, Obese | Glucagon-Like Peptide-1 Receptor - agonists | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2011, Volume 2013, Issue 7, pp. CD006423 - CD006423
Endocrine & metabolic | Hypoglycemic Agents | Diabetes Type 2 | Diabetes mellitus | Glycated Hemoglobin A | Type 2 Diabetes mellitus (formerly: non‐insulin‐dependent) | Glucagon‐Like Peptide 1 | Diabetes Mellitus, Type 2 | Diabetes mellitus and Related Disorders | Diabetes | Medicine General & Introductory Medical Sciences | Randomized Controlled Trials as Topic | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Glucagon-Like Peptide 1 - analogs & derivatives | Glycated Hemoglobin A - metabolism | Humans | Diabetes Mellitus, Type 2 - drug therapy | Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 9/2011, Volume 71, Issue 13, pp. 1675 - 1688
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Hormones. Endocrine system | Diabetes. Impaired glucose tolerance | Pharmacology. Drug treatments | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Glucagon-Like Peptide-1 Receptor | Glucagon-Like Peptide 1 - analogs & derivatives | Humans | Venoms - therapeutic use | Incretins - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Liraglutide | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Complications and side effects | Glucagon | Physiological aspects | Hypoglycemic agents | Dosage and administration | Research | Drug therapy | Index Medicus
Journal Article
European journal of pharmaceutics and biopharmaceutics, ISSN 0939-6411, 06/2017, Volume 115, pp. 257 - 267
Antidiabetic peptides | GLP-1 | Polymeric nanoparticles | Nano-carriers | Quality by design | Micelles | Diabetes | Liposomes | Insulin | Solid lipid nanoparticles | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Glucagon-Like Peptide 1 - administration & dosage | Hypoglycemic Agents - administration & dosage | Administration, Oral | Humans | Insulin - administration & dosage | Drug Delivery Systems - methods | Peptides - administration & dosage | Peptides | Diabetes therapy | Glucagon | Proteases | Mortality | Index Medicus
Journal Article
Biochemistry (Easton), ISSN 0006-2960, 07/2018, Volume 57, Issue 28, pp. 4148 - 4154
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Exenatide - analogs & derivatives | Amino Acid Sequence | Cell Line | Protein Conformation, alpha-Helical | Glucagon-Like Peptide 1 - metabolism | Glucagon-Like Peptide 1 - analogs & derivatives | Humans | Glucagon-Like Peptide-1 Receptor - chemistry | Crystallography, X-Ray | Glucagon-Like Peptide 1 - chemistry | Exenatide - chemistry | Molecular Dynamics Simulation | Glucagon-Like Peptide-1 Receptor - metabolism | Animals | Protein Conformation, beta-Strand | Protein Domains | Exenatide - metabolism | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 02/2015, Volume 58, Issue 3, pp. 1020 - 1037
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Insulin-Secreting Cells - metabolism | Animals | Glucagon-Like Peptide 1 - metabolism | Humans | Diabetes Mellitus - drug therapy | Diabetes Mellitus - metabolism | Molecular Imaging | Glucagon-Like Peptide 1 - therapeutic use | Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 2012, Volume 221, Issue 2, pp. 375 - 382
Cardiovascular | Oxidative stress | NF-κB | Endothelial cell | Inflammation | Apoptosis | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Cardiology. Vascular system | Blood vessels and receptors | Atherosclerosis (general aspects, experimental research) | Biological and medical sciences | Medical sciences | Vertebrates: cardiovascular system | Blood and lymphatic vessels | Tumor Necrosis Factor-alpha - metabolism | Phosphorylation | Reactive Oxygen Species - metabolism | Human Umbilical Vein Endothelial Cells - metabolism | Membrane Glycoproteins - metabolism | Protein Kinase C-alpha - metabolism | Apoptosis - drug effects | Humans | NADPH Oxidases - metabolism | Human Umbilical Vein Endothelial Cells - immunology | NF-kappa B - metabolism | I-kappa B Proteins - metabolism | Dose-Response Relationship, Drug | C-Reactive Protein - metabolism | Transfection | I-kappa B Kinase - metabolism | Time Factors | Inflammation Mediators - metabolism | Superoxide Dismutase - metabolism | Recombinant Proteins - metabolism | Glutathione Peroxidase - metabolism | Human Umbilical Vein Endothelial Cells - drug effects | Anti-Inflammatory Agents - pharmacology | Glucagon-Like Peptide 1 - analogs & derivatives | Cells, Cultured | Glucagon-Like Peptide 1 - pharmacology | Antioxidants - pharmacology | NADPH Oxidase 2 | Protein Transport | Catalase - metabolism | NF-kappa B - genetics | Signal Transduction - drug effects | Serum Amyloid P-Component - metabolism | Oxidative Stress - drug effects | Liraglutide | Index Medicus
Journal Article